215 Users Online
In-vivo Imaging Market Segmented By technology such as Optical imaging systems, Micro MRI, Nuclear imaging systems, Micro Ultrasound, Magnetic particle imaging systems, Photoacoustic imaging systems
In-vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. The in-vivo imaging systems has a deeper look into the tissues of living subjects. The benefits of this type of system is that it is succeeds in giving the most complete picture of the biological effects of a treatment or disease progression.
Usually in-vivo imaging systems are used in research laboratories to study the activity of a drug on the animals like albino rats, albino mice etc. On the other hand, to study the deformity or the disorder caused to the humans that may be disease induced, congenital or trauma induced Human In-vivo Imaging systems are used. The imaging systems used in this are similar to the ones use in animals like PET scan, SPECT scan, CT scan, MRI scan etc.
In- vivo imaging has many advantages and often replaces more cumbersome and inaccurate methods, such as measuring tumor volume with calipers, with more advanced technologies which more accurately determine volume and location which may drive the growth of in-vivo imaging market.
Technological advancement in the field of healthcare is expected to be the major factor to drive the growth of the In-vivo imaging market. The rise in market demand for non-invasive in-vivo imaging techniques is also another factor that may boost the growth of the market during the forecast period.
Rise in the rate of acceptance of multi-modality imaging systems in clinical and preclinical research studies and increasing awareness about the benefits of early diseases diagnosis are factors that are also expected to drive the growth of the in-vivo imaging market.
However, high cost of clinical and pre-clinical imaging systems, low healthcare expenditure in developing countries and uneven distribution of medical services over the regional boundaries may hinder the growth of the in-vivo imaging market.
|Based on technology||
|Based on application||
|Based on end-user||
In the modality segment, micro MRI is expected to have the highest revenue share during the forecast period. This is due to rise in disease burden and the efficiency of micro MRI in diagnosis of these diseases.
In the end user segment, diagnostic centers and hospitals are expected to generate high revenue during the forecast period owing to the increasing application of In-vivo imaging in these segments. However, due to rise in R&D activities research institutes may undergo significant growth.
Globally, the in-vivo imaging market is segmented into 5 regions, namely; North America, Latin America, Asia Pacific, Europe and Middle East & Africa.
North America is expected to have the largest share in the global market for in-vivo imaging due to increasing prevalence of cancer and high healthcare expenditure in this region. Europe is expected to hold 2nd largest no. of shares in the in-vivo imaging market as rapid advancement in healthcare services and technology will drive the growth of the market.
Asia Pacific is predicted to witness rapid growth during the forecast period due to new technologies being adopted in the medical sector by developing economies such as India and China, which are adopting. While in the Middle East & Africa, the market growth is expected to be limited owing to slow economic growth and underdeveloped technology.
Some of the players identified in the in-vivo imaging market include: